Antimicrobial peptides (AMPs) have been known as host-defense peptides. These cationic
and amphipathic peptides are relatively short (∼ 5–50 L-amino acids) with molecular weight …

Some antimicrobial peptides have been shown to be able to inhibit the proliferation of
cancer cell lines. Various strategies for treating cancers with active peptides have been …

Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many
organisms. Although AMPs have been essentially studied and developed as potential …

Anticancer peptides (ACPs) have emerged as a new class of therapeutic agent for cancer
treatment due to their lower toxicity as well as greater efficacy, selectivity and specificity …

Antimicrobial peptides (AMPs) are widespread in multicellular organisms. These structurally
diverse molecules are produced as the first line of defense against pathogens such as …

Antimicrobial peptides (AMPs) are a crucial part of innate immunity that exist in the most of
living organisms. In fact, AMPs have ability to incite the innate immune response and combat …

Despite recent advances in the treatment of colorectal cancer (CRC), low patient survival
rate due to emergence of drug resistant cancer cells, metastasis and multiple deleterious …

The global increase in cancer mortality and economic losses necessitates the cautious
quest for therapeutic agents with compensatory advantages over conventional therapies …

Antimicrobial peptides (AMPs) are important effectors of the innate immune system and play
a vital role in the prevention of infections. Due to the increased emergence of new antibiotic …

Cancer is a multifaceted global health issue and one of the leading causes of death
worldwide. In recent years, medical science has achieved great advances in the diagnosis …